Bianca Brundel, PhD

Bianca Brundel received her PhD from the University Medical Center Groningen, the Netherlands and was trained in molecular and cellular biology (VU, Amsterdam) and clinical pharmacology (UMCG). Since 2016, Bianca is professor at the physiology department at the Amsterdam UMC, location VU University Medical Center. Her research is focused on the molecular mechanisms driving proteostasis derailment and pathophysiology of cardiac diseases, including atrial fibrillation and cardiomyopathies. Molecular findings are used to identify novel druggable targets. Her laboratory utilizes experimental cardiomyocyte and Drosophila cardiac disease models in combination with genetic and pharmacological manipulations. The research of Brundel contributed to forwarding candidate drugs into (pre–)clinical proof–of-principle studies.

She is project leader of CIRCULAR, a project based on co–creation with Afib patients and StopAfib.org, which received recently funding from the Dutch government. Moreover she is lead author of the Nature Disease Primer ‘Atrial Fibrillation’ together with Mellanie True Hills and others and is founder of the Atrial Fibrillation Innovation Platform, to promote translational studies in collaboration with patients, researchers and health professionals.